Thursday 21 January 2016

NEJM Week of 17th December 2015 (#21)

Professor Brian Andrews NEJM Recommendations for Medical Students and Tutors
Week of the 17th December 2015 (#21)
University of Notre Dame Australia
(Fremantle Campus)


Occasional Editorial Comments

In 2016, every two weeks a Video in Clinical Medicine will be recommended for review from the NEJM video library.

Perspective

Why a GME (graduate medical education) Squeeze Is Unlikely (in the US).

 
This relates to the new medical schools (MD and DO graduates) in the US and the increased number of new interns generated by the process. Suffice it to say, there does not appear to be any shortage of basic training positions for US trained graduates projected through 2023-2024. However the number of IMG (international medical graduates), both US citizens who trained outside the US (42% of all IMGs who obtained internships in the US), e.g. in US approved Caribbean medical schools (first two years), or non-US IMGs will have progressive difficulty obtaining intern and residency training. Generally, the less sought after training positions are now frequently filled by IMGs and in the future will likely be filled by US graduates.
In some ways this is reminiscent of the current situation in WA. Currently with the marked budget deficit, it appears that additional intern and residency training positions will not increase, especially with the short-sighted cutbacks in public funded hospital teaching positions. Where will the increased number of medical graduates from the new Curtin Medical School (CMS) be trained? The government may be forced to fully reopen Fremantle Hospital (before they sell part of it off for short-term profit) and Royal Perth Hospital.
 If the US scenario is followed, one solution should be that international medical students (IMS) trained at WA medical schools will have to return to their own country for intern and residency training and not be guaranteed a postgraduate training position up front; this will be vigorously opposed by UWA and CMS who regard IMS as a “cash cow” for their institutions and an absolute fiscal requirement for such institutions as Syd U and Melb U.
Another area that must be addressed seriously in the future is an increase in the number of training positions in rural Australia which would necessitate more teaching staff and financial investment from the State and approval by the various Colleges.
                                                      
MUST READ SECTION

None

Articles Recommended for Medical Students

EDITORIAL

Antidote for Factor Xa Anticoagulants

http://www.nejm.org/doi/full/10.1056/NEJMe1513258


ORIGINAL ARTICLE

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity


Following on the reversal agent for the thrombin inhibitors (Idarucizumab for Dabigatran Reversal, http://www.nejm.org/doi/full/10.1056/NEJMoa1502000 ), there is now described a reversal agent for the factor Xa inhibitors e.g. rivaroxaban and apixaban which are approved for the prevention of stroke in patients with non-valvular atrial fibrillation. It is also of interest that this extremely expensive agent also reverses the effects of other factor Xa inhibitors that act through antithrombin, namely heparin and fonaparinux.

 

While the science behind the development of these monoclonal antibodies is wonderful, several points need to be made:

 

i)              This recombinant monoclonal antibody will be extremely expensive (as will be idarucizumab) and may not be generally approved for the Australian market, especially with the approval of the TPP

ii)             Treatment will require at least two IV infusions

iii)            As non-neutralizing antibodies are produced, what will happen with rechallenge in the future? Probably if a bleeding disorder occurs on one of these anticoagulants, the agent will have to be stopped in the patient.

iv)            Currently the data in human trials in patients who have bled has not yet been published, but expect this to be published in 2016 with positive results

v)             Look forward to the results of more studies using these anticoagulants in the prevention of DVT, treatment of DVTs  (Oral Rivaroxaban for Symptomatic Venous Thromboembolism, http://www.nejm.org/doi/full/10.1056/NEJMoa1007903 )

and the treatment of non-life threatening PEs. There is too much money (billions) to be made by Big Pharma with these anticoagulants and their reversal agents.

vi)            What happens if you give too much of the monoclonal antibodies (over-reversal)? Do patients then clot?

 

Please do not forget warfarin, an agent we know based on extensive evidence is effective, is cheap, but clearly has risks in particular intracerebral bleeding. However to monitor warfarin therapy carefully this takes up too much of the physician’s time and in the present practice climate of medicine, time is money. The latter may well end up being a major reason for the change from warfarin to the new oral anticoagulants.

ORIGINAL ARTICLE
BRIEF REPORT

Molecular Evidence of Sexual Transmission of Ebola Virus


A new sexually transmitted disease which is extremely well documented in a single case. The genital tract (and also the uveal tract) may result in a further reservoir for the virus until it rears its ugly head again in the next epidemic.

IMAGES IN CLINICAL MEDICINE

Scrub Typhus


An infection spread by a mite bite. Endemic in parts of Asia. Store this information in your brain stem but consider scrub typhus in a traveller exposed to mites as it is curable with doxycycline.

IMAGES IN CLINICAL MEDICINE

Achalasia with Megaesophagus


This is an extreme case of achalasia. You may see an occasional case during a GI rotation or for upper GI surgery, but this is still a very uncommon cause of dysphagia

Recommended learning: Review the causes of lower and upper oesophageal dysphagia and their management. Dysphagia is a very important area.

CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL

A 22-Year-Old Man with Hypoxemia and Shock

http://www.nejm.org/doi/full/10.1056/NEJMcpc1507212

 

An instructive case of a patient who presents with influenza pneumonia and develops acute respiratory distress syndrome (ARDS) and disseminated intravascular coagulation (DIC) associated with bacterial sepsis and an unexpected second viral infection which would not have been diagnosed if the patient had not had an autopsy!

 

Be careful after you obtain a total white cell count that you think in terms of absolute numbers of the various populations of white cells, not the percentage e.g. this patient as well as being markedly granulocytopaenic is also markedly lymphopenia and immunosuppressed.

 

Recommended learning: Review influenza A infection and pathology, immunization, appropriate use of antiviral agents in prevention; septic shock and SIRS, causes and management of DIC

 


Important Articles Related to Mechanisms of Disease and Translational Research

None

Other areas which should be of interest to medical students

Perspective

Peer-Review Fraud — Hacking the Scientific Publication Process


A new trend is the increasing numbers of scientific articles that are being retracted because of fake peer reviews.  This new type of fraud is made possible by electronic manuscript submission systems and inspired by academia's publish-or-perish ethos. What next!!

Interesting Follow-up Correspondence

CORRESPONDENCE

Cancer Screening in Unprovoked Venous Thromboembolism


This follow-up correspondence supports the earlier study (http://www.nejm.org/doi/full/10.1056/NEJMoa1506623 ) that suggested that in a patient with a new onset unprovoked venous thromboembolism in an otherwise asymptomatic patient that  an extensive diagnostic workup for cancer is unnecessary (that assumes that the patient has had a full H&P, including a rectal exam, breast exam and a pelvic exam with a Pap smear, a screening mammogram, FOBT and I believe also a PSA).